Ayant récemment obtenu la certification "logiciel d'aide à la prescription", la start-up Synapse Medicine se positionne comme alternative au Vidal. Sa plateforme permet de prévenir les risques liés à un traitement médical. Elle s'adresse aux médecins, pharmaciens, entreprises de télémédecine, assurances, mutuelles et grand public.

There has been a huge rise in people missing urgent cancer checks over the past year which has overwhelmed health services. Patients are facing long waits for treatment and it's been reported that the NHS cannot deal with this backlog, setting survival rates for some cancers back a decade. If we are to achieve the best possible outcome for everyone living with cancer, diagnosed or not, then technology is going to need to take a central role.

Consumers and benefits managers have a record number of digital health tools to choose from, according to a new report by the IQVIA Institute for Human Data Science.

The iPhone app would let people get glucose readings directly on their phone without using a reader. Users can scan a sensor built into the Freestyle Libre 2 to get their current glucose reading and trends. They can also share glucose readings and real-time alarms with caregivers. The app is cleared to be used by both adults and children, ages 4 and up.

The pandemic contributed to another 90,000 apps being introduced in 2020 – an average of 250 per day – and this coupled with rising number and functionality of wearable devices “provides evidence of digital health’s accelerating innovation,” according to the IQVIA Institute for Human Data Science’s 2021 trends report.

DTx (Digital Therapeutics) differs from the multitude of mental health apps on the market because they are meant to be prescribed or recommended by a health care professional; part of a comprehensive treatment plan; evidence-based; and subject to the same regulatory requirements as traditional medical treatments. The development of DTx is an area that affects patients, clinicians, payors, and policymakers. The Digital Health Alliance1 has put forth a 10-point list of core principles for DTx products as a first step in operationalizing the industry; these principles also help to distinguish DTx products from unregulated apps.

Decisions around digital mental health products for employees should be based not on marketing or their alleged popularity but on the evidence, engagement and the types of services associated with the product. Except for telehealth apps offering a synchronous (i.e., video or phone call) connection to a licensed therapist or psychiatrist, they should be used only to augment, not replace, evidence-based care. And when choosing these digital products, HR managers should strive to identify their employees’ specific needs and find the offerings that can best address them.

In short, mHealth is projected to keep growing, seeing more and more active users globally. In 2020, the market size for mHealth was valued at over $45 billion. The COVID-19 outbreak, however, triggered a drastic surge in market size, which is now projected to reach $100 billion (Statista) by the end of 2021 – a fivefold increase from $21 billion in 2016. North America was the dominant regional market in 2020 and accounted for a revenue share of 38.8%.

How can digital therapeutics more readily be brought into the hands of patients with serious mental illnesses?

Luttez contre le médicament de la rue avec Meditect ! Meditect est une application GRATUITE qui vous permet de vérifier l’authenticité de vos médicaments en quelques secondes grâce à un simple scan, et d'accéder à lla notice digitale.

A great report on Digital Health Trends from IQVIA.

Significant gaps remain in our understanding of Covid-19, and in many ways the coming period is going to be one of trial and error for nations. In particular, the asymptomatic nature of the virus in its early phase means that there is always a risk of unknown transmission. Governments will need effective trigger mechanisms – using novel data sources – and agile and responsive systems that enable them to act quickly if the reproduction number creeps up. Individuals may also want to take on greater responsibility for their health and disease detection, given the near universal failure of countries to price in risk and prepare for a pandemic, despite numerous warnings. With the power to both aggregate data and empower individuals, wearables could form part of a solution.

Delta tricks human cells into making way more copies of itself compared to previous variants. One study revealed that the viral load (number of viral copies) is 1,000 times higher for delta compared to the original SARS-CoV-2 strain. Viral load plays a big role in whether or not a person gets sick: if a person is exposed to higher levels of the virus, they are more likely to become infected.

You’ve probably heard a lot about vaccine passports this year: what they are, who’s making them and where you may be able to travel with one. That’s because a COVID-19 vaccine will be a new entry requirement for some destinations and travel providers, while others will use proof of vaccination to allow travelers to skip COVID-19 tests and mandatory quarantines.
Because vaccine passports will streamline the travel experience, they’re being seen as a crucial component of restarting the industry after the pandemic. But which countries are using (or plan to use) digital vaccine passports? And which countries aren’t?

As in other sectors, digital marketing can help healthcare players reach a much larger audience, create awareness to drive their cause and attract patients by leveraging digital channels like Facebook, Google and other digital platforms. Digital-marketing channels and tools became critical with the onset of the Covid-19 pandemic as clinicians were faced with a reduced ability to interact with patients directly at the clinic.

Their service offerings currently cover menopause, pregnancy, fertility and early parenthood. Peppy offers employees a secure online environment that not only gives users direct access to expert medical practitioners and tailored care but also provides an online community of users experiencing similar life changes. The app functions include instant messaging, group chats, video consultations, relevant articles, programmes and events.

There’s currently a lot of buzz around regulations for digital health, particularly in Europe with the EU Medical Device Regulations (MDR) which went into effect May 26 after a one year delay due to the Covid-19 pandemic. Digital health thought leader Mark Tarby, who serves as BrightInsight’s vice president of regulatory and quality management systems, shared his take on what the new regulations will mean for connected devices, Software as a Medical Device (SaMD), and the go-to market strategies for the companies behind them.

The combined company will look to create new patient engagement programs looking to balance in-person and digital care, Amwell said, focusing in the areas of virtual care automation and patient companionship in its longitudinal care, behavioral health and other specialty and chronic care segments.

Truepill’s Virtual Pharmacy platform works behind the scenes to help payers, PBMs and health systems alike create customized, digital storefronts for prescriptions and OTC products, ultimately lowering costs and modernizing the shopping experience. Furthermore, the new offering provides the opportunity to improve specific use cases for OTC benefit utilization by creating a simple destination for patients to redeem their benefits.

The change for HICAPS (Health Industry Claims and Payments Service) simplifies the claims process for Australian clients. Members of Medibank, Bupa, nib, and GU Health can now download their digital membership card from their health fund app, and add it to Apple Wallet. Rather than swiping a plastic card, users will instead be able to tap their iPhone or Apple Watch on any HICAPS terminal to make a claim. Real-time notifications will be provided to the user, provided via their health fund's app.

The health records will also show a physician ID of the treating doctor and facility ID of the healthcare facility visited. Having such an ID will allow patients to trace their medical records, maintain them on mobile devices and access them during emergencies.

The three-year-old company targets organisations who want to offer support to employees facing life events like menopause, pregnancy, fertility and early parenthood, offering a range of digital tools to provide support to people and connect them with expert practitioners. Services include instant messaging, group chat, video consultations, live events, evidence-based articles, videos and programmes, and corporate client s include major lawfirms, banks, retailers and public sector employers, including some NHS trusts.

The mWell launch signals the opening of this new digital health ecosystem. Currently, in partnership with CareSpan, Philcare, and Keralty Clinic, a whole gamut of doctors and health practitioners have joined the mWell roster comprising of general practitioners and specialty doctors to enable much-needed access to health professionals during this pandemic. Doctors are able to easily manage digital appointments, keep patients’ confidential medical records, and issue e-prescriptions. And with the partnership of Medicard, users can book COVID-19 testing services.

The accelerator, created by Amazon Web Services, will pick 10 healthcare startups in the U.S. using cloud-based services. To start, it will focus on solutions like remote patient monitoring, voice technology, analytics, patient engagement, and virtual care.

The digital health passport will initially focus on making sure passengers meet their testing requirements for the journey. In the future, the plan is to integrate vaccination credentials before the end of the summer. This latter feature will be more helpful in destinations that open up or have already opened up for vaccinated travelers.

Founded in 2013, the company got its start as a symptom-triage checker, but has quickly expanded. The company has expanded into hybrid care with its NHS-backed service GP at Hand, which allows patients in the U.K. to sign up for the service in lieu of registering with their local general practitioner. The service includes digital triage, online video visits and in-person care centers.

PharmStars is helping to bridge the “pharma-startup gap,” a disconnect between pharma and startups which often arises from differences in culture, communication, and timing. Digital health has the potential to transform the pharmaceutical industry and patient experiences. Pharma continues to have high unmet needs for innovative “beyond the molecule” solutions. Startups offer an untapped wealth of these potential solutions. Yet digital health startups and pharma have historically found it challenging to create successful partnerships.

The study found that 98.1% of participants had not used digital health services prior to the pandemic. Although 52.2% of participants felt these services could help to reduce non-essential contact, 77.8% were uncomfortable with artificial intelligence software interpreting their medical results and providing automatic advice.

Just weeks after its debut, the PharmStars digital health accelerator nabbed its first pharma members—Boehringer Ingelheim, Eli Lilly and Takeda. The new matchmaking company is the first of its kind to focus specifically on connecting drugmakers to digital health startups.
Founder and CEO Naomi Fried decided to launch the company after noticing a disconnect between pharma companies searching for digital health solutions and the entrepreneurial tech startups that were coming up with new ideas.

La situation sanitaire actuelle et le débat autour de la vaccination démontre la nécessité des citoyens/des patients d’être de plus en plus acteurs de leur santé et renforce aussi l’utilisation d’outils […]